Navigation Links
Rooting out recurrent breast cancer
Date:2/8/2013

Due to chemotherapy resistance and a high rate of relapse, triple negative cancers are among the most difficult breast cancers to treat. In this issue of the Journal of Clinical Investigation, researchers led by Carlos Arteaga at Vanderbilt University identified a protein, TGF-β, that is highly expressed in triple negative breast cancer cells after chemotherapy. In a mouse model of breast cancer, TGF-β both diverted cells down a path to becoming cancerous and allowed for cancer to come back after treatment. Importantly, loss of TGF-β prevented tumor recurrence in mice. These studies identify a mechanism by which cancer cells elude standard chemotherapy and provide a rationale for testing the therapeutic potential of agents that block TGF-β.


'/>"/>

Contact: Jillian Hurst
press_releases@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related medicine news :

1. Study drug is first to help patients with recurrent low-grade ovarian cancer
2. Unnecessary antimicrobial use increases risk of recurrent infectious diarrhea
3. Research shows that a prolonged fertility window can cause recurrent miscarriage
4. Common data determinants of recurrent cancer are broken, mislead researchers
5. Immune system changes may drive aggressiveness of recurrent tumors
6. Benefit of PET or PET/CT in recurrent bowel cancer is not proven
7. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
8. Daily Aspirin May Help Those at Risk for Recurrent Blood Clots
9. Study suggests new way to prevent recurrent ear infections
10. Current and former smokers at risk for recurrent hepatitis post-liver transplantation
11. Breast-Feeding Still Less Common for Black Babies: CDC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... blood glucose is associated with poor outcomes in hospitalized ... control hyperglycemia is a common practice in hospitals. But ... and even shows harms associated with the use of ... Clinical Guidelines Committee in a new evidence-based paper published ... Quality . , "Clinicians caring for hospitalized patients must ...
(Date:5/23/2013)... The sodium theory has ... B. Katz in the early 1950s, after their experiments ... sodium and potassium ions in nerve functions . ... techniques have known amazing developments. In The Sodium Theory ... an account of the latest developments in the field ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Orange County film ... release of ProLeak, light leaks for Apple's Final Cut ... for FCPX , you no longer have to worry about ... movement in your shot," Said Christina Austin, CEO of Pixel ... while maintaining a natural look." , ProLeak from Pixel Film ...
(Date:5/23/2013)... 2013 Dr. Damon Huffman of Huffman Family ... gum disease a revolutionary new treatment method with the Laser ... Americans who suffer from periodontal disease, and many of them ... Dr. Huffman is hoping that LANAP will encourage many of ... , Periodontal disease can cause gums to recede ...
(Date:5/23/2013)... 2013 Funeral Financials is encouraging American’s ... the EOD Memorial Foundation Funeral Financials considers ... victims from the war. , According to MarineEOD.com, ... before the U.S. was even at war. True ... with the Explosive Ordnance Disposal Badge. EOD technicians have ...
Breaking Medicine News(10 mins):Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 2Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 3Health News:Pixel Film Studios Releases ProLeak Light Leaks for Final Cut Pro X Today 2Health News:Humble, TX Dentist, Dr. Damon Huffman Now Offers Laser Periodontal Disease Treatment to Gum Disease Patients 2Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 2Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 3
... urges tighter controls for intravenous use, standardization of practices ... to control their own pain medication intravenously is four ... other medications, a new study says. , ... The Joint Commission Journal on Quality and Patient Safety ...
... VAR ) announced today that its Board of Directors ... 12, 2009 with a record date of December 15, 2008. The ... Camino Real, Palo Alto, California at 4:30 p.m. PT. , ... Thomson Financial and can be accessed at Varian Medical Systems, website ...
... BUTLER, N.J., Dec. 5 World Gourmet Marketing, LLC, creator,of ... provide healthier,snack alternatives at the concession stands of the IZOD ... time when obesity is a national concern, the Nets are ... The offerings,include: World Gourmet,s Sensible Portions Multi Grain Crisps, which ...
... Receives NASDAQ Deficiency Notice Relating to Market Value , ... LAVAL, QC, Dec. 5 /PRNewswire-FirstCall/ - BELLUS Health ... that in light of continuing significant fluctuations in world ... from the NASDAQ Capital Market, while continuing to maintain ...
... injuries caused by medical negligence moves into new suite on Washington Avenue ... ... The Law Offices of Christian A. Lodowski , a boutique law firm ... in Towson., , ,The firm has moved into an elegant suite at ...
... 5 Cell Therapeutics, Inc. ("CTI",or the "Company") (Nasdaq and MTA: ... "Modified Dutch Auction" tender offer to,purchase a portion or all of ... , -- 4% Convertible Senior Subordinated Notes due ... -- 6.75% Convertible Senior Notes due 2010, ...
Cached Medicine News:Health News:Self-Dosing Pain Medication Errors Too Common: Study 2Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Nets Provide Fans with Healthy In-Game Snack Option 2Health News:BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market 2Health News:BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market 3Health News:Law Offices of Christian Lodowski, Medical Malpractice Attorney, Relocates to New Office Park in Towson 2Health News:Cell Therapeutics, Inc. to Offer to Repurchase up to $124 Million of Its Notes 2Health News:Cell Therapeutics, Inc. to Offer to Repurchase up to $124 Million of Its Notes 3
(Date:5/23/2013)... DIEGO y PARÍS, 24 de mayo ... VOLC ), un destacado desarrollador y fabricante de ... mejorar la diagnosis y tratamiento de la enfermedad ... preliminares del ensayo ADVISE ( Ad enosine ... E valuation) II durante la sesión de ...
(Date:5/23/2013)... May 23, 2013 Amgen (NASDAQ: AMGN ... Annual  Healthcare Conference on Thursday, May 30, 2013, at the ... at 9:20 a.m. Eastern Daylight Time. Arvind Sood ... present at the conference. Live audio of the presentation can ... www.amgen.com , under Investors. A replay of the webcast will ...
(Date:5/23/2013)... Nephros, Inc. (OTC Bulletin Board: ... develops and sells high performance liquid purification ultrafilters, announced ... addition, the concurrent temporary reduction in exercise price for ... 2013. Nephros estimates that it will receive ... A portion of the proceeds will be used for ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... 13, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ... CSKI ), a leading fully integrated pharmaceutical company ... ("PRC"), today announced that it held its 2011 Annual ... 2011, in Harbin, PRC. At the Annual ...
... 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") ... in-vitro diagnostic ("IVD") company, today announced that China,s State ... Company,s real-time PCR-based V-Ki-ras2 Kirsten rat sarcoma viral oncogene ... companion diagnostic test for the use of a targeted ...
Cached Medicine Technology:China Sky One Medical, Inc. Elects Board Directors at its Annual Shareholders Meeting 2China Medical Technologies Receives SFDA Approval for its PCR-based KRAS Assay for Colorectal Cancer Targeted Drug 2
... The Medtronic Diagnostic Workstation is ... your gastrointestinal function testing needs. ... by allowing you to expand ... the consistency and reliability of ...
... using multi-channel catheters with secondary sensors placed ... catheter-based pH test also provides information about ... in the stomach or proximal esophageal acid ... pulmonary symptoms. Ability to record pH simultaneously ...
... Oxoid Pylori Test is ... for the qualitative detection of ... serum as an aid in ... H. pylori. The product is ...
... The Paragon CZE 2000 Capillary ... automate clinical serum protein electrophoresis (SPE), ... (IFE/s) for fast and accurate analysis. ... almost no sample preparation and no ...
Medicine Products: